Skip to main content
. 2023 Apr 25;9(2):e002995. doi: 10.1136/rmdopen-2023-002995

Table 3.

Logistic regression models to investigate associations with repair (n=17)

OR 95% CI P value
Duration of previous remission 1.005 0.802 to 1.26 0.963
Symptom duration at baseline (weeks) 0.972 0.95 to 1.00 0.051
Mean DAS from month 3 to time of repair 0.82 0.40 to 1.63 0.566
Previous prednisone 1.09 0.385 to 3.09 0.871
Previous infliximab 0.599 0.206 to 1.74 0.347
ACPA 1.51 0.413 to 5.53 0.533
Gender 1.13 0.401 to 3.16 0.822
Baseline age 1.01 0.975 to 1.05 0.548
BMI 1.03 1.00 to 1.05 0.056
Randomisation arm
 Sequential monotherapy Ref
 Step-up combination therapy 0.798 0.231 to 2.75 0.721
 Initial combination with prednisone 0.597 0.158 to 2.26 0.448
 Initial combination with infliximab 0.147 0.0173 to 1.25 0.080

All models were adjusted for mean Sharp/van der Heijde score until repair.

ACPA, anticitrullinated peptide antibody; DAS, disease activity score.